Pharma & Biotech

A remarkable 20% single-day surge in Ocugen's share price has returned the biotechnology firm to investor focus. The company, which...

A recent publication in the medical journal Dermatologic Therapy has provided a significant boost to the investment thesis for Sensus...

Shares of Oncology Institute demonstrated significant strength in Monday's trading session, propelled by the company's announcement of substantial cost savings...

Alector Inc finds itself at a pivotal moment as the biotechnology firm prepares to report crucial clinical trial data for...

Biotechnology firm Arvinas has unveiled a significant strategic overhaul, involving the potential out-licensing of a key breast cancer drug and...

Viking Therapeutics experienced significant selling pressure yesterday as investors reacted to Pfizer's unexpected acquisition of competitor Metsera. The biotech firm's...

Bayer's subsidiary AskBio has initiated a European Phase II clinical trial for its innovative gene therapy candidate, AB-1005, targeting Parkinson's...

Idorsia Ltd. shares are demonstrating notable strength in today's trading session, propelled by two significant strategic developments that are prompting...

Shares of Reviva Pharmaceuticals Holdings have been on a rollercoaster ride after the company disclosed the completion of a public...

The inclusion of Compass Therapeutics in the S&P Biotechnology Select Industry Index represents a significant validation for the clinical-stage biotech...